Gangaram Panday, Sanjiv S. G.
van Klaveren, David
Lagarde, Sjoerd M.
Lingsma, Hester F.
Mostert, Bianca
Coene, Peter-Paul L. O.
Dekker, Jan Willem T.
Hartgrink, Henk H.
Heisterkamp, Joos
Hutteman, Merlijn
Kouwenhoven, Ewout A.
Nieuwenhuijzen, Grard A. P.
Pierie, Jean-Pierre
van Sandick, Johanna W.
Sosef, Meindert N.
van der Zaag, Edwin S.
van Lanschot, J. Jan B.
Wijnhoven, Bas P. L.
,
Funding for this research was provided by:
KWF Kankerbestrijding (10825)
ZonMw (843004104)
Article History
Received: 24 June 2025
Accepted: 27 September 2025
First Online: 23 October 2025
Disclosure
: Bianca Mostert has a consultancy role for Lilly, Servier, BMS, Amgen, and AstraZeneca and receives research funding from BMS, Pfizer, and Sanofi. Ewout A. Kouwenhoven has a consultancy role for Intuitive Surgical. Marc J. van Det has a training and proctoring role for Intuitive Surgical. Bas P. L. Wijnhoven receives research funding from BMS and has a consultancy role for Medtronic. Misha D. Luyer receives funding from Galvani and Medtronic. The remaining authors have no conflicts of interest.